Executive brief
Data integrity in life sciences is the foundation for regulatory compliance, product quality, operational efficiency, and patient safety. As data volumes grow and organizations adopt more advanced digital tools, the ability to keep data accurate, consistent, complete, and accessible across its lifecycle becomes more important than ever.
For regulated companies, data integrity is not just a technical requirement. It is a business and compliance imperative. Weak integrity controls can undermine quality systems, create audit exposure, and reduce trust in the information used to guide critical decisions.
In life sciences, regulators expect organizations to manage electronic records in a way that protects traceability, accountability, and reliability. Requirements under Part 11 compliance and related global expectations make it clear that companies need secure systems, controlled access, and reviewable audit trails.
Without strong data integrity practices, organizations face real consequences, including inspection findings, recalls, remediation costs, reputational harm, and in severe cases, operational shutdowns or license risk. Strong controls help reduce those outcomes while supporting inspection readiness.
Maintaining data integrity across life sciences operations is difficult because organizations work across multiple systems, formats, business functions, and regulatory requirements. Data must remain reliable from creation through storage, archival, review, and reporting.
Managing high-volume data from research, clinical trials, production, and quality operations
Maintaining consistent access controls so only authorized users can work with sensitive data